Eventide Asset Management - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,783,667
-41.4%
372,665
-24.4%
0.21%
-37.6%
Q2 2023$20,113,593
+9.4%
493,2220.0%0.34%
+0.9%
Q1 2023$18,382,384
+65.2%
493,222
+54.6%
0.34%
+53.9%
Q4 2022$11,129,910
-37.7%
319,0000.0%0.22%
-37.6%
Q3 2022$17,851,000
-41.1%
319,000
-42.1%
0.35%
-24.5%
Q4 2020$30,327,000551,4000.46%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders